{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T22:32:25Z","timestamp":1791325945729,"version":"4.3.1"},"reference-count":56,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T00:00:00Z","timestamp":1731369600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:p>Schizophrenia is a multifaceted psychiatric disorder with a complex etiology that includes genetic, environmental, and immunological factors. Emerging research has increasingly focused on the role of the immune system, particularly neutrophils, in the pathogenesis of schizophrenia. Neutrophils, the most abundant type of white blood cells, are crucial in the body\u2019s defense mechanisms against infections and in the regulation of inflammation. This review explores the evolving evidence that implicates neutrophils in schizophrenia, highlighting their potential contribution to the disorder\u2019s onset and progression through mechanisms such as neuroinflammation and oxidative stress. Recent studies have demonstrated elevated neutrophil counts and neutrophil-to-lymphocyte ratios (NLR) in individuals with schizophrenia, correlating with the severity of psychotic symptoms and cognitive impairments. Furthermore, genetic and molecular analyses have revealed abnormalities in neutrophil function and immune-related gene expression in schizophrenia patients. These findings suggest that neutrophil dysfunction and the resulting chronic inflammation could play a significant role in the disorder\u2019s pathophysiology, affecting neuronal function, and contributing to the clinical manifestations of schizophrenia. Neutrophil-related biomarkers, such as NLR, could aid in the diagnosis and monitoring of disease progression. Additionally, targeting neutrophil activity and associated inflammatory pathways presents a promising avenue for developing new therapeutic interventions. This review underscores the need for further research to elucidate the precise mechanisms by which neutrophils influence schizophrenia and to explore potential treatments that could improve outcomes for patients.<\/jats:p>","DOI":"10.1097\/ms9.0000000000002744","type":"journal-article","created":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T14:01:09Z","timestamp":1731333669000},"page":"1360-1369","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["From immune response to mental health: neutrophils in schizophrenia"],"prefix":"10.1097","volume":"87","author":[{"given":"Emmanuel Ifeanyi","family":"Obeagu","sequence":"first","affiliation":[{"name":"Department of Biomedical and Laboratory Science, Africa University, Zimbabwe"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Getrude Uzoma","family":"Obeagu","sequence":"additional","affiliation":[{"name":"School of Nursing Science, Kampala International University, Ishaka, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,11,12]]},"reference":[{"key":"R1-20250422","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1093\/schbul\/sby058","article-title":"Global epidemiology and burden of schizophrenia: findings from the global burden of disease study 2016","volume":"44","author":"Charlson","year":"2018","journal-title":"Schizophr Bull"},{"key":"R2-20250422","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2147\/JBM.S451988","article-title":"Eosinophils and cognitive impairment in schizophrenia: a new perspective","volume":"15","author":"Obeagu","year":"2024","journal-title":"J Blood Med"},{"key":"R3-20250422","doi-asserted-by":"crossref","first-page":"e38380","DOI":"10.1097\/MD.0000000000038380","article-title":"Exploring the role of eosinophil cationic protein (ECP) in schizophrenia: insights and implications","volume":"103","author":"Obeagu","year":"2024","journal-title":"Medicine (Baltimore)"},{"key":"R4-20250422","first-page":"29","article-title":"Gender-based assessment of tumour necrosis factor\u2013alpha and interleukin\u20136 of patients with Schizophrenia in Nigeria","volume":"9","author":"Obeagu","year":"2022","journal-title":"Int J Adv Res Biol Sci"},{"key":"R5-20250422","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1002\/dneu.22044","article-title":"Immune system gene dysregulation in autism and schizophrenia","volume":"72","author":"Michel","year":"2012","journal-title":"Dev Neurobiol"},{"key":"R6-20250422","first-page":"107","article-title":"Neutrophils to lymphocytes ratio and some cytokines in patients with schizophrenia in southeast, Nigeria","volume":"5","author":"Obeagu","year":"2022","journal-title":"Int J Res Rep Hematol"},{"key":"R7-20250422","first-page":"47","article-title":"Neutrophil to lymphocyte ratio and some cytokines in pateints with schizophrenia after antipsychotic therapy in southeast, Nigeria","volume":"5","author":"Obeagu","year":"2022","journal-title":"As J Med Principl Clin Pract"},{"key":"R8-20250422","first-page":"43","article-title":"Ceruloplasmin and HIV-associated psychiatric disorders: a review","volume":"1","author":"Obeagu","year":"2023","journal-title":"Elite J Laborat Med"},{"key":"R9-20250422","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1080\/08039488.2021.1919201","article-title":"The severity of inflammation in major neuropsychiatric disorders: comparison of neutrophil\u2013 lymphocyte and platelet\u2013lymphocyte ratios between schizophrenia, bipolar mania, bipolar depression, major depressive disorder, and obsessive compulsive disorder","volume":"75","author":"Bulut","year":"2021","journal-title":"Nord J Psychiatry"},{"key":"R10-20250422","doi-asserted-by":"crossref","first-page":"728990","DOI":"10.3389\/fpsyt.2021.728990","article-title":"Is elevated neutrophil count and neutrophil-to-lymphocyte ratio a cause or consequence of schizophrenia? \u2014a scoping review","volume":"12","author":"Sandberg","year":"2021","journal-title":"Front Psychiatry"},{"key":"R11-20250422","doi-asserted-by":"crossref","first-page":"581061","DOI":"10.3389\/fpsyt.2020.581061","article-title":"Neutrophil-to-lymphocyte ratio is independently associated with severe psychopathology in schizophrenia and is changed by antipsychotic administration: a large-scale cross-sectional retrospective study","volume":"11","author":"Zhou","year":"2020","journal-title":"Front Psychiatry"},{"key":"R12-20250422","doi-asserted-by":"crossref","first-page":"965169","DOI":"10.3389\/fnagi.2022.965169","article-title":"The role of neutrophils in the dysfunction of central nervous system barriers","volume":"14","author":"Santos-Lima","year":"2022","journal-title":"Front Aging Neurosci"},{"key":"R13-20250422","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.schres.2019.05.028","article-title":"The association between schizophrenia and the immune system: review of the evidence from unbiased \u2018omic-studies","volume":"217","author":"van Mierlo","year":"2020","journal-title":"Schizophr Res"},{"key":"R14-20250422","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.schres.2019.02.005","article-title":"A genetics perspective on the role of the (neuro) immune system in schizophrenia","volume":"217","author":"Birnbaum","year":"2020","journal-title":"Schizophr Res"},{"key":"R15-20250422","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0149-7634(03)00035-6","article-title":"Schizophrenia: from phenomenology to neurobiology","volume":"27","author":"Wong","year":"2003","journal-title":"Neurosci Biobehav Rev"},{"key":"R16-20250422","doi-asserted-by":"crossref","first-page":"767175","DOI":"10.3389\/fimmu.2021.767175","article-title":"Neutrophils\u2014from bone marrow to first-line defense of the innate immune system","volume":"12","author":"Kraus","year":"2021","journal-title":"Front Immunol"},{"key":"R17-20250422","doi-asserted-by":"crossref","first-page":"274","DOI":"10.3389\/fncel.2020.00274","article-title":"The inflamed brain in schizophrenia: the convergence of genetic and environmental risk factors that lead to uncontrolled neuroinflammation","volume":"14","author":"Comer","year":"2020","journal-title":"Front Cell Neurosci"},{"key":"R18-20250422","doi-asserted-by":"crossref","first-page":"503","DOI":"10.4149\/BLL_2023_077","article-title":"Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as inflammation markers for early-onset schizophrenia","volume":"124","author":"Gercek","year":"2023","journal-title":"Bratislava Med J"},{"key":"R19-20250422","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.schres.2018.12.017","article-title":"Neutrophil-to-lymphocyte ratio in schizophrenia: a systematic review and meta-analysis","volume":"206","author":"Karageorgiou","year":"2019","journal-title":"Schizophr Res"},{"key":"R20-20250422","doi-asserted-by":"crossref","first-page":"880568","DOI":"10.3389\/fpsyt.2022.880568","article-title":"Immune system abnormalities in schizophrenia: an integrative view and translational perspectives","volume":"13","author":"Ermakov","year":"2022","journal-title":"Front Psychiatry"},{"key":"R21-20250422","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.schres.2014.09.004","article-title":"Genetic liability for schizophrenia predicts risk of immune disorders","volume":"159","author":"Stringer","year":"2014","journal-title":"Schizophr Res"},{"key":"R22-20250422","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-62703-845-4_1","article-title":"The role of neutrophils in the immune system: an overview","author":"Malech","year":"2014","journal-title":"Neutrophil Methods Protocols"},{"key":"R23-20250422","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41398-022-02197-1","article-title":"Microglia sequelae: brain signature of innate immunity in schizophrenia","volume":"12","author":"Rodrigues-Neves","year":"2022","journal-title":"Transl Psychiatry"},{"key":"R24-20250422","doi-asserted-by":"crossref","first-page":"496638","DOI":"10.3389\/fpsyt.2019.00892","article-title":"Cytokine alterations in schizophrenia: an updated review","volume":"10","author":"Momtazmanesh","year":"2019","journal-title":"Front Psychiatry"},{"key":"R25-20250422","doi-asserted-by":"crossref","first-page":"703452","DOI":"10.3389\/fpsyt.2021.703452","article-title":"Oxidative stress and the pathophysiology and symptom profile of schizophrenia spectrum disorders","volume":"12","author":"Murray","year":"2021","journal-title":"Front Psychiatry"},{"key":"R26-20250422","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.bbi.2022.07.006","article-title":"Neutrophil-lymphocyte ratios as inflammatory biomarkers in psychiatric patients","volume":"105","author":"Bhikram","year":"2022","journal-title":"Brain Behav Immun"},{"key":"R27-20250422","doi-asserted-by":"crossref","first-page":"902","DOI":"10.30773\/pi.2020.0185","article-title":"C-reactive protein\/albumin and neutrophil\/ albumin ratios as novel inflammatory markers in patients with schizophrenia","volume":"17","author":"Balcioglu","year":"2020","journal-title":"Psychiatry Investig"},{"key":"R28-20250422","doi-asserted-by":"crossref","first-page":"12586","DOI":"10.1038\/s41598-017-12986-0","article-title":"Associations between SNPs and immune-related circulating proteins in schizophrenia","volume":"7","author":"Chan","year":"2017","journal-title":"Sci Rep"},{"key":"R29-20250422","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1093\/jnen\/62.6.593","article-title":"The blood-brain barrier and its role in immune privilege in the central nervous system","volume":"62","author":"Pachter","year":"2003","journal-title":"J Neuropathol Experiment Neurol"},{"key":"R30-20250422","doi-asserted-by":"crossref","first-page":"429","DOI":"10.5455\/bcp.20161123044657","article-title":"Neuroinflammation in schizophrenia: a critical review and the future","volume":"26","author":"Aricioglu","year":"2016","journal-title":"Klinik Psikofarmakoloji B\u00fclteni-Bull Clin Psychopharmacol"},{"key":"R31-20250422","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/schbul\/sbn121","article-title":"Association between prenatal exposure to bacterial infection and risk of schizophrenia","volume":"35","author":"S\u00f8rensen","year":"2009","journal-title":"Schizophr Bull"},{"key":"R32-20250422","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1097\/NMD.0000000000000049","article-title":"The role of early life stress in adult psychiatric disorders: a systematic review according to childhood trauma subtypes","volume":"201","author":"Carr","year":"2013","journal-title":"J Nerv Ment Dis"},{"key":"R33-20250422","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.schres.2016.10.003","article-title":"Environmental pollution and risk of psychotic disorders: a review of the science to date","volume":"181","author":"Attademo","year":"2017","journal-title":"Schizophr Res"},{"key":"R34-20250422","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0165-1781(03)00222-1","article-title":"Overproduction of neutrophil radical oxygen species correlates with negative symptoms in schizophrenic patients: parallel studies on neutrophil chemotaxis, superoxide production and bactericidal activity","volume":"121","author":"Sirota","year":"2003","journal-title":"Psychiatry Res"},{"key":"R35-20250422","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1586\/ern.09.144","article-title":"The mononuclear phagocyte system and its cytokine inflammatory networks in schizophrenia and bipolar disorder","volume":"10","author":"Drexhage","year":"2010","journal-title":"Expert Rev Neurother"},{"key":"R36-20250422","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3389\/fpsyt.2018.00060","article-title":"Sterile inflammation of brain, due to activation of innate immunity, as a culprit in psychiatric disorders","volume":"9","author":"Ratajczak","year":"2018","journal-title":"Front Psychiatry"},{"key":"R37-20250422","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/s41583-020-0263-9","article-title":"Immune cell regulation of glia during CNS injury and disease","volume":"21","author":"Greenhalgh","year":"2020","journal-title":"Nat Rev Neurosci"},{"key":"R38-20250422","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.pnpbp.2011.11.003","article-title":"Developmental neuroinflammation and schizophrenia","volume":"42","author":"Meyer","year":"2013","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatr"},{"key":"R39-20250422","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1037\/abn0000554","article-title":"Heterogeneity of emotional experience in schizophrenia: Trait affect profiles predict clinical presentation and functional outcome","volume":"129","author":"Cowan","year":"2020","journal-title":"J Abnorm Psychol"},{"key":"R41-20250422","doi-asserted-by":"crossref","first-page":"106054","DOI":"10.1016\/j.nbd.2023.106054","article-title":"Astroglia support, regulate and reinforce brain barriers","volume":"179","author":"Verkhratsky","year":"2023","journal-title":"Neurobiol Dis"},{"key":"R42-20250422","doi-asserted-by":"crossref","first-page":"676621","DOI":"10.3389\/fimmu.2021.676621","article-title":"Immune response in neurological pathology: emerging role of central and peripheral immune crosstalk","volume":"12","author":"Passaro","year":"2021","journal-title":"Front Immunol"},{"key":"R43-20250422","doi-asserted-by":"crossref","first-page":"a020479","DOI":"10.1101\/cshperspect.a020479","article-title":"Oligodendrocytes: myelination and axonal support","volume":"8","author":"Simons","year":"2016","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"R44-20250422","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.3389\/fimmu.2020.01024","article-title":"Interaction of microglia and astrocytes in the neurovascular unit","volume":"11","author":"Liu","year":"2020","journal-title":"Front Immunol"},{"key":"R45-20250422","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.bbi.2017.03.003","article-title":"Resveratrol regulates microglia M1\/M2 polarization via PGC-1\u03b1 in conditions of neuroinflammatory injury","volume":"64","author":"Yang","year":"2017","journal-title":"Brain Behav Immun"},{"key":"R46-20250422","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.neulet.2014.10.016","article-title":"Mitochondrial ROS govern the LPS-induced pro-inflammatory response in microglia cells by regulating MAPK and NF-\u03baB pathways","volume":"584","author":"Park","year":"2015","journal-title":"Neurosci Lett"},{"key":"R47-20250422","doi-asserted-by":"crossref","first-page":"8448","DOI":"10.3390\/molecules27238448","article-title":"Emerging potential of the phosphodiesterase (PDE) inhibitor ibudilast for neurodegenerative diseases:an update on preclinical and clinical evidence","volume":"27","author":"Angelopoulou","year":"2022","journal-title":"Molecules"},{"key":"R48-20250422","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/S0140-6736(02)07718-8","article-title":"Adverse reactions to TNF-\u03b1 inhibitors in rheumatoid arthritis","volume":"359","author":"Day","year":"2002","journal-title":"The Lancet"},{"key":"R49-20250422","doi-asserted-by":"crossref","first-page":"100034","DOI":"10.1016\/j.bbih.2019.100034","article-title":"Neuroinflammation and glial cell activation in mental disorders","volume":"2","author":"Almeida","year":"2020","journal-title":"Brain Behav Immunity Health"},{"key":"R50-20250422","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.4252\/wjsc.v13.i8.1072","article-title":"Mesenchymal stem cells as a potential therapeutic tool to cure cognitive impairment caused by neuroinflammation","volume":"13","author":"Skok","year":"2021","journal-title":"World J Stem Cells"},{"key":"R51-20250422","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/brb3.208","article-title":"N-acetylcysteine (NAC) in neurological disorders: mechanisms of action and therapeutic opportunities","volume":"4","author":"Bavarsad Shahripour","year":"2014","journal-title":"Brain Behav"},{"key":"R53-20250422","doi-asserted-by":"crossref","first-page":"574776","DOI":"10.3389\/fnagi.2020.574776","article-title":"Parkinson\u2019s disease with depression: the correlations between neuroinflammatory factors and neurotransmitters in cerebrospinal fluid","volume":"12","author":"Lian","year":"2020","journal-title":"Front Aging Neurosci"},{"key":"R54-20250422","doi-asserted-by":"crossref","first-page":"917","DOI":"10.3390\/nu14050917","article-title":"Emerging evidence for the widespread role of glutamatergic dysfunction in neuropsychiatric diseases","volume":"14","author":"McGrath","year":"2022","journal-title":"Nutrients"},{"key":"R55-20250422","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3389\/fncel.2020.00090","article-title":"Going the extra (synaptic) mile: excitotoxicity as the road toward neurodegenerative diseases","volume":"14","author":"Armada-Moreira","year":"2020","journal-title":"Front Cell Neurosci"},{"key":"R56-20250422","doi-asserted-by":"crossref","first-page":"18","DOI":"10.4306\/pi.2016.13.1.18","article-title":"Bipolar disorder: role of inflammation and the development of disease biomarkers","volume":"13","author":"Muneer","year":"2016","journal-title":"Psychiatry Investig"},{"key":"R57-20250422","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/npp.2016.199","article-title":"Inflammation, glutamate, and glia: a trio of trouble in mood disorders","volume":"42","author":"Haroon","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"R58-20250422","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1517\/14728222.2016.1121237","article-title":"Changing paradigm to target microglia in neurodegenerative diseases: from anti-inflammatory strategy to active immunomodulation","volume":"20","author":"Pena-Altamira","year":"2016","journal-title":"Expert Opin Ther Targets"}],"container-title":["Annals of Medicine &amp; Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MS9.0000000000002744","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T09:01:06Z","timestamp":1745312466000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MS9.0000000000002744"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,12]]},"references-count":56,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/ms9.0000000000002744","relation":{},"ISSN":["2049-0801"],"issn-type":[{"value":"2049-0801","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,12]]},"assertion":[{"value":"2024-06-14","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-05","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}